chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Interchange of vaccine products; Tested positive again/Has the patient received a COVID-19 vaccination? Yes, 25Feb2021 Moderna/25Mar2021 Moderna/08Nov2021 Moderna/13Mar2022 Pfizer; Tested positive again/Has the patient received a COVID-19 vaccination? Yes, 25Feb2021 Moderna/25Mar2021 Moderna/08Nov2021 Moderna/13Mar2022 Pfizer; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 56-year-old female patient received BNT162b2 (BNT162B2), on 13Mar2022 as dose 4 (booster) single (Batch/Lot number: unknown) at the age of 55 years for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 25Feb2021 as dose 1, single (Batch/Lot number: unknown), on 25Mar2021 as dose 2, single (Batch/Lot number: unknown) and on 08Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "Is the patient a smoker/Formed smoker: No" (unspecified if ongoing), notes: Is the patient a smoker/Formed smoker: No. The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 13Mar2022, outcome "unknown"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "Tested positive again/Has the patient received a COVID-19 vaccination? Yes, 25Feb2021 Moderna/25Mar2021 Moderna/08Nov2021 Moderna/13Mar2022 Pfizer". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (18Apr2022) Positive, notes: positive test at home; (2022) Negative, notes: tested negative for several days; (2022) Positive, notes: symptoms returned and test positive for another week. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: The reported COVID-19 positive after BNT162B2 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported events and BNT162B2 administration.The causal association between the at-risk event interchange of vaccine products and the use of suspect product BNT162B2 cannot be fully excluded.
Information has been received from a physician concerning a female who was vaccinated with Gardasil and was later found to have HPV. Medical attention was sought. The patient's outcome was not reported. Additional information has been requested.
The evening of the first injection, I was on the toilet and experienced what felt like a food intolerance reaction since I already live with IBS. My defecation was not clean and concise but instead drawn out and sloppy. When I could no longer defecate, my intestines continued to impulsively "try" to push out more. What came out after the solid mass of fecal matter was a clear liquid that excreted in waves.  The clear liquid would come out, then stop, all while the anus was very inflamed and muscle contractions felt like more was still to come even though none would come until a few minutes later. This horrible experience lasted for between 6 and 7 hours, and in fact did not stop. I simply decided to hold it in the rest of the night so I could rest for a few hours. It was very difficult to sleep in this condition. When I got up in the morning, a large amount of the clear liquid came out in the form of a gel "blob" all at once and then the spasms ended and I felt no more need to defecate. This exact same scenario played out again with my second injection almost a month later on 11/12/2021. Also, since the first night of trauma that I experienced, my hemorrhoids have worsened permanently in that they now "sweat" during the night and day, mildly excreting a gel like substance from time to time. I also now seem unable to digest insoluble fiber very well at all and my bowel movements at night are slow and incomplete without longer periods on the toilet if I consume insoluble fiber. If I avoid it, I appear to have normal bowel movements.
Breastfeeding 18 month old daughter and at about 10:00PM, twelve hours after I received the first shot of Moderna on my right arm, my daughter experienced a fever of about 101 degrees. I undressed my daughter and gave her Tylenol and within the hour, her fever went down to 97 degrees.
Within first 15 minutes of observation patient was noted to have new rash by parent. No respiratory distress noted and no angioedema noted.  Patient was taken to pediatric clinic within medical center for further MD evaluation per pediatrician request.
This spontaneous report was received from a pharmacist regarding a 57 year old female patient with no pertinent medical history reported and with no drug reactions or allergies. On 07-AUG-2013 the patient was vaccinated with ZOSTAVAX (lot # J000433, expiration date 10-APR-2014) (0.65 ml, subcutaneous) for "Prevent shingles". No other suspect therapies were reported. Concomitant therapies included PROTONIX, hydrochlorothiazide, LOPRESSOR and potassium. The pharmacist reported that on 09-AUG-2013 the patient called to report that she noted a red, raised area of the unspecified injection site which measured "5 inches by 2 inches". This pharmacist stated that she was going to recommend to the patient to administer oral BENADRYL and ZYRTEC to manage the symptoms. The outcome for red, raised area of the unspecified injection site was reported as not recovered. It was reported that the patient sought medical attention by calling the pharmacist. The pharmacist did not assess the causality between ZOSTAVAX and red, raised area of the unspecified injection site. Additional information has been requested.
I caught Covid (again after having it in Jan 2021) in April. I missed a week of work.
On June 19th I developed a tiny rash on my hip and began spotting in between my period, something that never happens. The spotting only lasted one day and although I was concerned, I read that this is common with women who get vaccinated.  This past weekend however, on June 26th, I began itching extremely bad near the top of my vagina. I wasn't sure what it was as it wasn't occuring anywhere near the opening of my vagina, but closer to the top under the abdomen. The itching began spreading all over my body, from my scalp to the webs of my fingers, my ears and face, toes, everywhere! Bumps that resemble lots of mosquito bites or hives initially began forming on my stomach yesterday, now I have bumps on the back of my neck, my arms, stomach and back and I have an intense, now burning itch all over my body.
Lot of pain on her arm; rash appeared down her arm; Cellulitis; A spontaneous report was received from other healthcare professional concerning a 34-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced cellulitis with seriousness criteria of medically significant, rash and painful arm.  The patient's medical history, as provided by the reporter, included migraines, scoliosis, and anxiety. Concomitant medications reported included sertraline (100mg once daily). On 04 Jan 2021, prior to the onset of the events, the patient received the first of two planned doses of mRNA-1273 (Lot number: 039K20-2A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 12 Jan 2021, the patient experienced cellulitis and rash.  On an unspecified date, patient experienced rash down her arm and a lot of pain on arm.  Lab details were not provided by the reporter.  Treatment for the events included steroids, antibiotic, diphenhydramine and non-drowsy antihistamines.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events, cellulitis, rash, rash appeared down her arm and a lot of pain on arm were recovered on 18 Jan 2021.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Hives, itchy feeling in throat and eyes mild allergic reaction. 50mg Benadryl give via IM injection to right arm.
Patient felt light-headed after vaccination. Denies and chest pain and shortness of breath. No nausea vomiting. No loss of consciousness.
Experienced dizziness and nausea the night of the flu shots next morning. Decided to eat lunch then Friday (10/31) and felt better for approx. 1 hr. Then left work vomited and was very tired. Slept rest of afternoon and night. Tired Saturday but no more vomiting or dizziness.
Pt taken to ER due to fever inc to 104.5 r; Advil administered & mom advised to given q4-6hrs PRN; Pt still running 102r fever on 26JUL91 was taken to MD; Md states pt should only have DT here after;
This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 26-year-old female subject who was vaccinated with BOOSTRIX, (GlaxoSmithKline). On 19 May 2014 the subject received unspecified dose of BOOSTRIX (.5 ml, intramuscular). The subject's last menstrual period date was on 28 October 2013 and her estimated date of delivery was on 12 August 2014. The subject was exposed to the vaccine during her third trimester of pregnancy. At the time of reporting, the pregnancy was ongoing. Follow-up information received on 06 October 2014 from nurse: The VAERS details were provided. This was a normal conception. Some of the patient's details were provided. On 10 August 2014, 83 days after the vaccination with BOOSTRIX, the subject gave birth to a male live infant, by normal vaginal delivery. This was a full-term pregnancy. The infant had an Apgar score of [8-9], a weight of 8 1.3lb, a height of 21 inches, a cranial circumference of 14 inches.
feeling cold along her back; left arm injection site is very hard; left arm injection site is painful; thinks that she received 2.5ml for a booster dose of the Moderna COVID-19 vaccine instead of the 0.25ml for her booster dose; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (feeling cold along her back), VACCINATION SITE INDURATION (left arm injection site is very hard), VACCINATION SITE PAIN (left arm injection site is painful) and ACCIDENTAL OVERDOSE (thinks that she received 2.5ml for a booster dose of the Moderna COVID-19 vaccine instead of the 0.25ml for her booster dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    No Medical History information was reported.  On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2.5 milliliter. On an unknown date, the patient experienced FEELING COLD (feeling cold along her back), VACCINATION SITE INDURATION (left arm injection site is very hard), VACCINATION SITE PAIN (left arm injection site is painful) and ACCIDENTAL OVERDOSE (thinks that she received 2.5ml for a booster dose of the Moderna COVID-19 vaccine instead of the 0.25ml for her booster dose). At the time of the report, FEELING COLD (feeling cold along her back), VACCINATION SITE INDURATION (left arm injection site is very hard) and VACCINATION SITE PAIN (left arm injection site is painful) outcome was unknown and ACCIDENTAL OVERDOSE (thinks that she received 2.5ml for a booster dose of the Moderna COVID-19 vaccine instead of the 0.25ml for her booster dose) had resolved.  Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.  The patient had refused to provider her date of birth or age and also refused to provide an e-mail address.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 01-Feb-2022: Follow up document contains no significant information.
Client received first vaccine on 03/13/2021. Client states woke on 03/29/2021 and noted right hand was swollen with itchy, red raised areas. Client states seen physician on 03/30/2021 and was given an antibiotic and ointment. Client received second vaccine on 04/03/2021 and when he woke on 04/04/2021 he had similar symptoms he had to his right hand to his neck, left armpit, and right calf area; symptoms consist of itchy red raised "bump" areas. Client states the "bumps" are intermittent and last approximately 3 days, but prior to the bump resolving new bump appear each day. Client states right hand symptoms resolved on 05/01/2021.
Fatigue; General sickness; This non-serious case was reported by a consumer via sales rep and described the occurrence of fatigue in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced fatigue (Verbatim: Fatigue) and feeling unwell (Verbatim: General sickness). The outcome of the fatigue and feeling unwell were resolved (duration 24 hrs).   It was unknown if the reporter considered the fatigue and feeling unwell to be related to Shingrix.     It was unknown if the company considered the fatigue and feeling unwell to be related to Shingrix.   Additional Information: GSK Receipt Date: 28-JUL-2023 The reporter's sister experienced adverse experience of fatigue and general sickness after Shingrix. The adverse events were resolved within 24 hours. The reporter did not consent to follow up.
Chills; Malaise; Hives; Other vaccine same date details: [{other vaccine same date product= Pfizer/Bio, other vaccine same date vaccine date= 08Jan2021}]; Other vaccine same date details: [{other vaccine same date product= Pfizer/Bio, other vaccine same date vaccine date= 08Jan2021}]; This is a spontaneous report from a contactable other hcp. A 66-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number unknown, intramuscular on 08Jan2021 11:30 at a SINGLE DOSE and via an unspecified route of administration on 08Jan2021 at a SINGLE DOSE for covid-19 immunisation. Other vaccine same date details: [{other vaccine same date product= Pfizer/Bio, other vaccine same date vaccine date= 08Jan2021}]. Medical history included drug hypersensitivity to Penicillin from an unknown date and unknown if ongoing. Concomitant medication included lisinopril (LISINOPRIL) and atorvastatin (ATORVASTATIN). The patient previously took clindamycin and experienced drug hypersensitivity.  The patient experienced Hives, Chills, Malaise on 08Jan2021 18:00. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
The same day of my first injection of COVID-19 Vaccine EUA, I developed a very large red bump (4 inches in diameter) at the injection site (my right arm) that was raised, swollen, hard, and sore, and lasted for about 5 days.  On the 6th day after the injection, I developed a persistent itch on my face, which spread to my neck, and then my chest. The itch turned into hives, which is unusual for me (I have never had hives or an allergic reaction before). I have not used any new products, eaten any new foods, or done anything out of my routine, leading me to believe it is most likely a reaction to the vaccine. The symptoms were alleviated by taking Benadryl, but continued to persist mildly throughout the night and the following day.
This spontaneous report as received from a healthcare worker refers to 16 year old patient of unknown gender. On 13-AUG-2015, the patient was vaccinated with a dose of improperly stored GARDASIL (Lot # K011562, expiration date 08-APR-2017) (strength, dose and route were not provided). No adverse effects reported. This is one of several reports from the same source. Additional information has been requested.
Sore arm from shot but resolved on day 5. Day 8 I woke up with itching at the injection site as well as a large, hard golf ball size lump at the site. Red but no raised rash .
Arm pain (not at injection site) within minutes of injection, decreasing but still persisting 8 days later.
Dizziness & Palpitations Narrative:  Employee started experiencing anxiety ready team called and employee taken to ER for observation.
Information has been received from a women in a physician's office concerning a 12 month old female with no medical history who on 31-MAY-2006 was vaccinated in the right thigh with the first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (+) varicella virus vaccine live (Lot # 652328/0956R). There was no illness at the time of vaccination. The woman reported that on 12-JUN-2006, 12 days post vaccination, the patient developed a rash on her arms and legs characterized by 25-30 pinpoint lesions. It was unknown if medical attention was sought and no laboratory/diagnostic tests were performed. Subsequently, the patient's rash resolved. This is a consolidation of two reports concerning the same patient. No further information is available.
I developed acute genital ulcers on 1/7/2021, 2 days after receiving the second dose (1/5/2021). No history of STIs or exposures (not sexually active). I did also have a single ~2 cm tender axillary lymphadenopathy on the site of the vaccination that persisted for ~4 days, as well as body aches at 12-36h after vaccination. No inguinal lymphadenopathy, fever, chills.  I visited the doctor on day 5 of genital ulcers at which time HSV and VZV testing were performed which were both negative. Due to possibility of it being shingles (I did have chickenpox as a child), I took a 7 day-course of valacyclovir. Ulcers began to resolve around day 7 after onset and resolved completely after about 2 weeks with no recurrence.
Patient came back to pharmacy on 6/1/18 after receiving the 2 vaccinations here on 5/26/18. Her left arm was swollen and red. She stated it was also hot to the touch and itchy. Her arm had been that way for several days, she said. I recommended she take a Benadryl orally and place an ice pack on the arm. I also suggested she take an Aleve if the arm was painful or bothersome to her. I asked her if she was allergic to anything and she stated only penicillin. I told her I would put both vaccines on her allergy profile today.
Patient given Moderna vaccine at an age not authorized. Given full dose of primary series 0.5mL.
Patient called Health Department on 10/27/22 stating she had swelling and pain on left clavicle/neck. Patient concerned that swelling/pain was from influenza vaccine. This RN advised patient to follow up with physician/seek care. This RN called patient on 10/28/22 and patient went to healthcare provider, but is awaiting results; symptoms remain the same. This RN called patient on 10/31/22 and patient is awaiting results.
patient became light headed within 5 minutes of receiving 2nd dose and developed a headache subsequently.  after about 30 minutes patient went home with family.  she had no other symptoms and no treatment was provided.  patient was advised to hydrate, take some tylenol if needed and to rest for the remainder of the day. we offered to call rescue and it was declined.  upon follow-up later that evening, husband stated she was doing better
LITTLE TIREDNESS; This spontaneous report received from a patient (Nurse) concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: Patient was a nurse. The patient previously received covid-19 vaccine ad26.cov2.s (unspecified manufacturer) (Dose number in series 1) (suspension for injection, route of admin not reported, batch number and expiry date unknown) dose was not reported, 1 total, administered on unspecified date for prophylactic vaccination.  It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26. cov2.s (Dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin, and batch number were not reported, expiry date: unknown) dose was not reported, 1 total, administered in right arm on 2022 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date in 2022, the patient experienced little tiredness (Dose number in series 2). Patient stated that, a little tiredness a day after taking her booster J and J covid-19 vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of little tiredness was not reported. This report was non-serious.
Pt presented to clinic for 3rd dose of Covid vaccine. After pt received the vaccine, she left the room and went to the front desk to talk to the PCT. She talked to the PCT for approx. 1-2 minutes and the PCT notified this NP that the Patient was saying she was Short of breath. I went to the front desk and the patient was in and out of consciousness. This NP, eased patient to the floor once patient went unconscious. This Np, examined pt for pulse using stethoscope and pulse oximeter, with no pulse noted or breathing. Next, I started CPR and told the PCT to call 911. I continued to perform high quality CPR for 2-3 minutes and the patient regained Consciousness almost simultaneous as the police and fire department arrived. Pt was alert, oriented, and talking with the police and her father arrived to the store. The patient  was confirmed to be breathing and noted to have a regular pulse prior to her being  placed on a stretcher by the fire and police department.
Occipital Neuralgia after the first shot of Moderna. COVID vaccine.  Very sharp pain on the right side of my head. I take Gabapentin 6 times a day for pain. Nothing else helps.
Dizziness, lightheadedness about 15 minutes following vaccination. Cold compress applied, blood pressure taken (154/92), 911 called after onset of heavy breathing. BP taken again (132/84), glucose (87). Portable EKG results unremarkable.
day after the vaccine, her arm started to hurt, the pain is radiating to the back.  Fatigue Headache congestion cough weakness
Easily short of breath, winded; weak; Chest heaviness and mild pain with tightness; Chest heaviness and mild pain with tightness; Lung heaviness and mild pain with tightness; Lung heaviness and mild pain with tightness; breathing heavier; lightheaded; This is a spontaneous report from a contactable consumer (patient). A 39-year-old female patient (not pregnant) received the first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number and expiration date unknown) via an unspecified route of administration on 03May2021 16:00 (39-year-old at time of vaccination), at single dose, for COVID-19 immunization. The patient's medical history Lupus, fibromyalgia, Lyme, neuropathy, and allergies to Latex. Concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 03May2021 19:00, patient experienced Chest/Lung heaviness and mild pain with tightness; Easily short of breath, winded and weak; unable to perform daily routine, breathing heavier is also making her lightheaded. Prior to vaccination, the patient was not diagnosed with COVID-19; since the vaccination, the patient has not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Narrative: 90yo male patient has a past medical h.o. malignant bladder cancer with occasional hematuria (denies any recently), HTN, COPD, HLD, pacemaker placement, malignant prostate cancer, and atrial fibrillation (on metoprolol and warfarin), Colonic Pseudo obstruction, who was a home hospice patient but transferred to hospice at nursing home facility with hospice unit. Pt died in hospice unit at this facility on 12/26/2021. Pt had received covid vaccines prior to moving to state from state, so received vaccines from outside city hospital facility on 2/5/21 & 3/5/21. This death was not related to vaccines given pt's hospice status from morbidities and advanced age.